Research Paper Volume 15, Issue 24 pp 14803—14829
Investigating the ID3/SLC22A4 as immune-related signatures in ischemic stroke
Figure 6. Expression validation in vivo models. (A) ID3 expression patterns in IS patients and controls in discovery set. (B) SLC22A4 expression patterns in IS patients and controls in discovery set. (C) The mRNA levels of ID3 in mouse brain tissues. (D) The mRNA levels of SLC22A4 in mouse brain tissues. (E, F) The protein levels of ID3 in mouse brain tissues. (G, H) The protein levels of SLC22A4 in mouse brain tissues. (I) The immunofluorescence levels of ID3 and SLC22A4 in mouse brain tissues. MCAO group and sham group, number of mice per group n=6.